Kingdon Capital Management, L.L.C. Deciphera Pharmaceuticals, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$19.95 - $38.85 $5.91 Million - $11.5 Million	-296,346 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $2.34 Million - $2.92 Million	111,352 Added 60.19%	296,346 $6.68 Million
Q1 2019 May 14, 2019	BUY	$20.65 - $29.55 $3.82 Million - $5.47 Million	184,994 New	184,994 $4.29 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.